The Role of Platelets in Diabetic Kidney Disease

Area of Science:

• Nephrology
• Diabetology
• Hematology

Background:

• Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease globally.
• DKD pathogenesis involves intricate systemic and intra-renal inflammatory and coagulation pathways.
• Activated platelets are increasingly recognized for their role in DKD progression.

Purpose of the Study:

• To review the current understanding of platelet involvement in DKD pathogenesis.
• To summarize evidence on the therapeutic potential of antiplatelet agents in DKD.
• To highlight the role of platelets in inflammation, coagulation, and fibrosis in DKD.

Main Methods:

• Literature review of animal models and clinical trials.
• Synthesis of current knowledge on platelet function in DKD.
• Analysis of antiplatelet therapy efficacy in DKD management.

Main Results:

• Platelets are pivotal in DKD's inflammatory, coagulation, and fibrotic processes.
• Evidence from preclinical and clinical studies suggests a role for platelets in DKD progression.
• Antiplatelet agents show potential therapeutic benefits in preventing DKD advancement.

Conclusions:

• Platelets significantly contribute to the complex pathogenesis of diabetic kidney disease.
• Antiplatelet therapies represent a promising avenue for managing and preventing DKD progression.
• Further research into platelet-targeted interventions is warranted for DKD patients.